Investor Relations

  • Corporate Governance
  • Announcements
  • Financial Reports
  • Company Presentations
  • Stock Price
  • Analyst Coverage
  • Investor Relations Contacts
  • 'Notices(Replacement of Lost Share Certificates)

The Board

FU Yuning - Chairman of the Board

Mr. FU Yuning, was appointed as the chairman of the Board and a Director in December 2014 and designated as a non-executive Director in June 2016. Mr. FU also serves as the chairman of China Resources (Holdings) Company Limited, a member of the 12th session of the Chinese People’s Political Consultative Conference, a member and vice chairman of APEC China Business Council, the honorary chairman of the Hong Kong Chinese Enterprises Association and a member of the General Committee of the Hong Kong General Chamber of Commerce. He served as the chairman of China Merchants Port Holdings Company Limited (formerly known as China Merchants Holdings (International) Company Limited), a company listed on the Stock Exchange (stock code: 0144), an independent non-executive director of CapitaLand Limited, a company listed on the Singapore Exchange Limited (stock code: C31), the chairman of China Merchants Group Limited, the chairman of China Merchants Bank Co., Ltd., a company listed on the Shanghai Stock Exchange (stock code: 600036) and the Stock Exchange (stock code: 03968) and an independent non-executive director of Li & Fung Limited, a company listed on the Stock Exchange (stock code: 0494). Mr. FU holds a doctorate degree from Brunel University in the United Kingdom.

WANG Chuncheng - Executive Directors

Mr. WANG Chuncheng, was appointed as a Director in December 2014, designated as an executive Director in June 2016 and appointed as the chief executive officer in June 2016. Mr. WANG also serves as an assistant general manager of China Resources (Holdings) Company Limited, the chairman of CR Pharmaceutical Holdings Company Limited, the chairman of China Resources Pharmaceutical Commercial Group Company Limited, the chairman of China Resources Double-Crane Pharmaceutical Co., Ltd., the chairman of Dong-E-E-Jiao Company Limited, a vice chairman of Chinese Pharmaceutical Enterprises Association, and a director of the board of the International Federation of Pharmaceutical Wholesalers (IFPW). Mr. WANG has over 20 years of experience in corporate management. He served as a deputy director of the department of human resources of the Ministry of Foreign Trade and Economic Cooperation (currently known as Ministry of Commerce), a general manager of the human resources department and an assistant general manager of China Resources National Corporation, a general manager of the standing board office of China Resources (Holdings) Company Limited, the chairman of Teck Soon Hong Limited, and the chairman of China Resources Textiles Holdings Co Ltd. (華潤紡織(集團)有限公司). Mr. WANG holds a bachelor’s degree in economics from Jilin Institute of Finance and Trade (currently known as Jilin University of Finance and Economics) in Changchun, the PRC.
 

SONG Qing - Executive Directors

Mr. SONG Qing, was appointed as a Director in May 2016, designated as an executive Director in June 2016 and appointed as the president on June 2017. Mr. SONG also serves as the chairman and a director of China Resources Sanjiu Medical & Pharmaceutical Company Limited. Mr. SONG has over 30 years of experience in the pharmaceutical industry and corporate management. He served as an inspection pharmacist of quality inspection department, a pharmacist in charge and the director of production department, the director of the enterprise management department and an assistant to president of Shenzhen South Pharmaceutical Factory (the predecessor of China Resources Sanjiu Medical & Pharmaceutical Company Limited), the general manager and chairman of Shanxi Sanjiu Tongda Pharmaceutical Company Limited(山西三九同達藥業有限公司) (currently known as Shanxi Tongda Pharmaceutical Company Limited(山西同達藥業有限公司)). Mr. SONG served as an assistant to general manager, the director of technology center, the director of medical & pharmaceutical department of Sanjiu Enterprise. Mr. SONG obtained his chief pharmacist title from the general logistics department of the People’s Liberation Army in April 1996. Mr. SONG holds a bachelor’s degree in Chinese medicine from Anhui University of Traditional Chinese Medicine in Hefei, the PRC.

LI Guohui - Executive Directors

Mr. LI Guohui, was appointed as a Director in March 2016 and designated as an executive Director in June 2016. Mr. LI also serves as the chief financial officer and vice president of our Company, a director of China Resources Double-Crane Pharmaceutical Company Limited, a director of Dong-E-E-Jiao Company Limited and a supervisor of China Resources Sanjiu Medical & Pharmaceutical Company Limited. Mr. LI has over 10 years of experience in financial and business analysis and financial management. Mr. LI joined China Resources (Holdings) Company Limited in 2009 and served as the chief accounting officer of the finance department from September 2011. Mr. LI obtained a bachelor’s degree in shipbuilding techniques and equipment from the Faculty of Naval Architecture and Ocean Engineering of Wuhan Institute of Water Transportation Engineering (currently known as Wuhan University of Technology) in Wuhan, the PRC. He holds a master’s degree in business administration from Wuhan University, the PRC and a master’s degree in financial management from Nanyang Technological University in Singapore. Mr. LI is a CFA charter holder and a certified accountant of the Institute of Certified Public Accountant of Singapore.

CHEN Rong - Non-executive Directors

Mr. CHEN Rong, was appointed as General Manager of the Finance Department of China Resources (Holdings) Company Limited in February 2016. Mr. CHEN was appointed as non-executive director of China Resources Beer (Holdings) Company Limited (formerly known as China Resources Enterprise, Limited), a company listed on the Stock Exchange (stock code: 291) in April 2016, a non-executive director of China Resources Land Limited, a company listed on the Stock Exchange (stock code: 1109) and a Director in May 2016 and designated as a non-executive Director in June 2016. Mr. CHEN has previously worked in Epson Technical Limited, Walmart China Investment Limited and Fuji Electric Technical Services Limited. Mr. CHEN joined CR Holdings in May 2007, he was the head of tax management of the Finance Department of China Resources (Holdings) Company Limited and deputy general manager and chief financial officer of China Resources Vanguard Company Limited. Mr. CHEN holds MBA degree from Xi’an Jiaotong University. He is an Intermediate Accountant and a Certified Tax Agent in China. He is also a non-practicing member of the Chinese Institute of Certified Public Accountants.

YU Zhongliang - Non-executive Directors

Mr. YU Zhongliang, as appointed as a non-executive Director in
June 2016. Mr. YU also serves as a senior deputy general manager of the strategy management department of China Resources (Holdings) Company Limited. Mr. YU has over 20 years of experience in investment, business analysis and strategic development. Mr. YU was successively the strategic development controller, an executive director and a vice chairman of China Resources Cement Holdings Limited, a company listed on the Stock Exchange (stock code: 1313). Mr. YU holds an MBA degree of York University in Toronto, Canada.

WANG Chenyang - Non-executive Directors

Mr. WANG Chenyang, was appointed as a Director in June 2015 and designated as a non-executive Director in June 2016. Mr. WANG also serves as a deputy general manager of the Beijing State-Owned Capital Operations and Management Centre, a director of Avic Aviation HighTechnology Co. Ltd.(中航航空高科技股份有限公司), a company listed on Shanghai Stock Exchange (stock code: 600862), and a non-executive director of CSC Financial Co., Ltd.(中信建投證券股份有限公司), a company listed on the Stock Exchange (stock code: 6066). Mr. WANG has over 10 years of experience in management. He served as a senior staff member and an assistant consultant of the Division for Management of Officials of Publicity, Education, Political-Legal Affairs of the Organization Department of Beijing Municipal Committee of the Communist Party of China( 中共北京市委組織部宣教政法幹部處), a division-level cadre of the General Office of Beijing Municipal Committee and a deputy bureau-level cadre of the General Office of Beijing Municipal Government. Mr. WANG obtained a bachelor’s degree in Chinese language and literature from University of International Relations in Beijing and a master of arts degree in journalism from Renmin University of China.

WANG Jing - Non-executive Directors

Ms. WANG Jing, was appointed as a non-executive Director in June 2016. Ms. WANG also serves as a deputy general manager of the Beijing State-Owned Capital Operations and Management Centre, a director of BOE Technology Group Co. Ltd.(京東方科技集團股份有限公司), a company listed on Shenzhen Stock Exchange (stock code: 000725 (A share), 200725 (B share)), a non-executive director of BAIC Motor Corporation Ltd. (北京汽車股份有限公司), a company listed on the Stock Exchange (stock code: 1958), and a supervisor of CSC Financial Co., Ltd.(中信建投証券股份有限公司), a company listed on the Stock Exchange (stock code: 6066). Ms. WANG has over 10 years of experience in investment and management. She served as a manager of the enterprise management department of Beijing Enterprise Holdings Investment Management Co. Ltd.(北京控股投資管理有限公司), a deputy general manager of Beijing Holdings Investment Management Center(北京京泰投資管理中心) and held various positions in Beijing Holdings Ltd.(京泰(實業)集團有限公司), including a manager of the enterprise operation and management department and an assistant to general manager, and the chairman and general manager of Beijing Inland Port International Logistics Co. Ltd.(陸港國際物流有限公司). Ms. WANG obtained the qualification of senior economist issued by Senior Professional Qualification Appraisal Board of Beijing(北京市高級專業技術資格評審委員會)in September 2005 and the qualification of corporate legal advisor issued by the Ministry of Human Resources and Social Security of the PRC(中華人民共和國人力資源和社會保障部), the SASAC and the Ministry of Justice in October 2008. Ms. WANG obtained a bachelor of economics degree in finance from Beijing Institute of Finance and Trade (currently known as Capital University of Economics and Business), a master of law degree in economic law from Renmin University of China and a master’s degree in business administration from Murdoch University in Perth, Australia.

SHING Mo Han Yvonne - Independent Non-executive Directors

Mdm. SHING Mo Han Yvomme, BBS, JP, was appointed as an independent non-executive Director in August 2017. Mdm. SHING was appointed as a Justice of Peace by the HKSAR Government in 2013 and awarded Bronze Bauhinia Star in 2017. Mdm. SHING is currently the chairman of Yinn Advisory Services Limited. Mdm. SHING was a partner of Deloitte China for over 26 years until her retirement in May 2016. She is also a member of the 10th,11th and 12th Jiangsu Provincial Committee of the Chinese People’s Political Consultative Conference. Mdm. SHING is a founding member and past president of the Association of Women Accountants (Hong Kong) and the past chairman of Hong Kong Institute of Certified Public Accountants Taxation Committee. She is now the vice-chairman of Hong Kong General Chamber of Commerce Tax Committee, council member of Association of Women Accountants (Hong Kong), and member of Chinese General Chamber of Commerce. Her professional qualifications include fellow member of the Hong Kong Institute of Certified Public Accountants, Association of Chartered Certified Accountants and Institute of Chartered Secretaries and Administrators. Mdm. SHING’s current public appointments include treasurer of the Council of the Hong Kong Academy for Performing Arts, member of the Corruption Prevention Advisory Committee of the Independent Commission Against Corruption, member of the Antiquities Advisory Board, member of the Communications Authority, member of the Advisory Committee on Built Heritage Conservation, court member of the Hong Kong Polytechnic University, and advisor and member of the Finance Committee of Our Hong Kong Foundation. In 2006, Mdm. SHING received the National Hundred Outstanding Women Entrepreneurs Award in Great Hall of the People in Beijing. She also received the Outstanding Alumni Award of Hong Kong Polytechnic University in 2007. Mdm. SHING has been consecutively named from 2001 to 2015 in International Tax Review as one of the World’s Leading Tax Advisors in Hong Kong and Mainland. Mdm. SHING graduated from the Hong Kong Polytechnic (currently known as the Hong Kong Polytechnic University) and obtained a Higher Diploma in Accountancy and is 2016/2017 University Fellow of the Hong Kong Polytechnic University.
 

KWOK Kin Fun - Independent Non-executive Directors

Mr. KWOK Kin Fun, BBS, JP, was appointed as an independent non-executive Director in June 2016. Mr. KWOK also serves as an Executive Committee member of Rehabilitation International and global Vice Chairman of Social Commission of Rehabilitation International, the chairman of Incheon Strategy Group Committee of Asia and Pacific Disability Forum, a vice chairman of The Hong Kong Joint Council for People with Disabilities, a vice chairman of The Hong Kong Society for Rehabilitation, the chairman of Fu Hong Society, a member of Ethics Research Committee of Hospital Authority Kowloon Central and Kowloon East Clusters, a member of Voting Members Committee of Riding For the Disabled Association, the chairman of Accessible IT Development Association Limited. Mr. KWOK has over 30 years of experience in disability research and medical research ethics. He successively served as a senior lecturer, a principal lecturer, a university senior lecturer and an associate professor of the City University of Hong Kong from 1985 to 2009, and after retirement served as full-time and part-time senior research fellow. Mr. KWOK was appointed as a Justice of the Peace (JP) by the government of Hong Kong in 1997 and received the Bronze Bauhinia Star awarded by the government of Hong Kong SAR in 2005, “Kazuo Itoga” Memorial Prize awarded by the government of Shiga Prefecture, Japan in 2006, and the Promoter title of “Asian and Pacific Decade of Persons with Disabilities, 2013–2022” awarded by United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP) in 2012. Mr. KWOK holds a bachelor’s degree in social science from the University of Hong Kong, a master’s degree in social science from the Chinese University of Hong Kong, and a Ph.D. degree from the University of Nottingham, the UK.

FU Tingmei - Independent Non-executive Directors

Mr. FU Tingmei, was appointed as an independent non-executive Director in June 2016. Mr. FU has over 20 years of experience in investment,finance, law and business management. Mr. FU currently serves as an independent non-executive director of CPMC Holdings Limited, a company listed on the Stock Exchange (stock code: 0906), Guotai Junan International Holdings Limited, a company listed on the Stock Exchange (stock code: 1788), Postal Savings Bank of China Co., Ltd., a company listed on the Stock Exchange (stock code: 1658) and COFCO Meat Holdings Limited, a company listed on the Stock Exchange (stock code: 1610). Mr. FU holds a master’s degree in law and a Ph.D. degree in law from London University, the United Kingdom.

ZHANG Kejian - Independent Non-executive Directors

Mr. ZHANG Kejian, was appointed as an independent non-executive Director in June 2016. Mr. ZHANG also serves as an independent director of Yifan Pharmaceutical Co., Ltd. (a company listed on Shenzhen Stock Exchange, stock code: 002019), an independent director of CR Double-Crane and the Chief Scientist of The South China Center for Innovative Pharmaceuticals. Mr. ZHANG has over 20 years of experience in the pharmaceutical industry of PRC. He was employed as a professor of School of Pharmaceutical Sciences of Sun Yat-sen University and the director (Pharmacy Administration) of The South China Center for Innovative Pharmaceuticals, a researcher at the Institute of Medicine, Chinese Academy of Medical Sciences(中國醫學科學院藥物研究所), and successively served as a deputy director of Pharmaceutical Evaluation Center(藥品審評中心)and a deputy director of Medical Device Evaluation Center(醫療器械技術審評中心)under the State Food and Drug Administration of the PRC(國家食品藥品監督管理局). Mr. ZHANG received a master’s degree in pathophysiology from China Medical University in Shenyang, the PRC and a doctor’s degree in pharmacy from the School of Pharmaceutical Sciences of Chiba University in Chiba, Japan.